Characterization of Type I Receptors for Transforming Growth Factor-β and Activin

Peter ten Dijke(Ludwig Cancer Research), Hidetoshi Yamashita(Ludwig Cancer Research), Hidenori Ichijo(Tokyo Medical and Dental University), Petra Franzèn(Ludwig Cancer Research), Marikki Laiho(University of Helsinki), Kohei Miyazono(Ludwig Cancer Research), Carl‐Henrik Heldin(Ludwig Cancer Research)
Science
April 1, 1994
Cited by 553

Abstract

Transforming growth factor-beta (TGF-beta) and activin exert their effects by binding to heteromeric complexes of type I and type II receptors. The type II receptors for TGF-beta and activin are transmembrane serine-threonine kinases; a series of related receptors, denoted activin receptor-like kinase (ALK) 1 to 5, have recently been identified, and ALK-6 is described here. ALK-5 has been shown to be a functional TGF-beta type I receptor. A systematic analysis revealed that most ALKs formed heteromeric complexes with the type II receptors for TGF-beta and activin after overexpression in COS cells; however, among the six ALKs, only ALK-5 was a functional TGF-beta type I receptor for activation of plasminogen activator inhibitor-1, and only ALK-2 and ALK-4 bound activin with high affinity.


Related Papers

No related papers found

Powered by citation graph analysis